EN DE

Lana Medical Company (9587) Fair Value & Analysis

Healthcare · SA · Market cap 135M SAR

LM Lana Medical Company 9587 · SR
Price2.50 SAR
Fair Value1.00 SAR
Upside-60.0%
Quality26/100
Expensive Growth
Thin margins · 2.9% net margin
Low debt · negative free cash flow
Mixed vs. peers (7/12)
Narrow moat 29/100
Watch Lana Medical Company for free, get notified when fair value or trend changes. Watch for free
Evidence: Medium Range 0.7500 SAR – 1.25 SAR Share as image

Fair value as of: Aug 1, 2026

From 14 valuation models · updated today

Share price −10.7% over the past month.

What matters now

  • The price sits above even our optimistic bull case (1.25 SAR). The favourable scenario is already priced in.
  • Weak quality (26/100) and above fair value at the same time, the margin of safety is missing on both counts.

Price vs Fair Value (12 months)

1,000,000 SAR 2.07 SAR Fair Value 1.00 SAR Aug 2025 Jul 2026

12‑month range 2.07 SAR – 1,000,000 SAR · fair‑value band 0.7500 SAR – 1.25 SAR · the 2.50 SAR price screens above the 1.00 SAR fair value. As of Aug 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Lana Medical Company (9587) currently trades at 2.50 SAR, while our model-based Fair Value estimate is 1.00 SAR, implying the stock looks roughly 60.0% overvalued today. We read business quality at 26/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Lana Medical Company generated revenue of 92.3M SAR at a net margin of 2.9%. Revenue declined 11.6% year over year. It earns a return on equity of 4.3%. Net debt stands at 15.7M SAR. Fundamentals as of Aug 1, 2026

Our scenario range runs from 0.7500 SAR (bear case) to 1.25 SAR (bull case); at 2.50 SAR, the current price sits above that range. For context, the median of 10 Healthcare peers we cover trades at 24% fair-value upside, at -60%, 9587 screens richer than that median.

Key figures & financial health

Revenue (TTM) 92.3M SAR
Revenue growth (YoY) -11.6%
Net margin 2.9%
Return on equity 4.3%
Free cash flow −10.4M SAR FY2025
P/E ratio 50.0
More key figures
Operating margin 7.6%
EPS (TTM) 0.0500 SAR
EPS growth (YoY) -92.3%
Net debt 15.7M SAR FY2025

Figures from reported company fundamentals · as of Aug 1, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 26/100
Profitability 31
Quality Growth 10
Cashflow 0
Fin. Strength 57
Investment 42
Low Volatility 50
Momentum 26
52W Momentum 0
Net Issuance 41

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Lana Medical Company provides medical services to healthcare sector in the Kingdom of Saudi Arabia. The company operates through five segments: Medical Waste Management, Sale of Medical Equipment, Sale of Medical Supplies, Construction, and Rental.

Full company description

Lana Medical Company provides medical services to healthcare sector in the Kingdom of Saudi Arabia. The company operates through five segments: Medical Waste Management, Sale of Medical Equipment, Sale of Medical Supplies, Construction, and Rental. It offers medical devices, including laser hair removal, C02 fractional laser technology, non-surgical HIFU tightening technique, and skin care. The company also provides medical equipment maintenance; medical supplies; and health care products, including emergency coverage for construction sites and medical services for industrial facilities and cities, medical coverage for projects and events, equipping and operating primary medical clinics, private ambulance services, home hemodialysis services, and health escort rental services. In addition, it offers infection control solutions; and medical and industrial, pharmaceutical and pharmaceutical, chemical, and slaughterhouse waste management, as well as carbon ash management, non-hazardous waste, public health pests, food health and safety, and environmental consulting services. Further, the company is involved in dealing with transfer and disposal of hazardous and organic waste services; construction of residential and non-residential buildings; leasing of containers for transportation of construction debris; production of plastic supplies; and construction waste management and investment services. Additionally, it engages in the maintenance and cleaning of hospitals, medical centers, and general medical complexes; import and export activities; operation of hazardous medical waste treatment facilities and final disposal of hazardous waste; separating and sorting metal and non-metal waste, and scraps and other articles into secondary raw materials; and retail sale of medical equipment, tools, and supplies. Lana Medical Company was founded in 2010 and is based in Riyadh, the Kingdom of Saudi Arabia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Lana Medical Company reported revenue of 92.3M SAR in FY2025 versus 32.0M SAR in FY2021, a compound +30.4%/yr. Reported net income was 2.7M SAR in FY2025, compounding −20.0%/yr from FY2021.

Revenue +30.4%/yr
FY21 32.0M SAR
FY22 40.8M SAR
FY23 48.6M SAR
FY24 84.1M SAR
FY25 92.3M SAR
Net income −20.0%/yr
FY21 6.6M SAR
FY22 5.5M SAR
FY23 3.0M SAR
FY24 8.0M SAR
FY25 2.7M SAR

Is 9587 fairly valued? → Check now

Share or link this analysis
📋 Free embed code + live data for your site

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Lana Medical Company Fair Value". https://www.fairvalue-calculator.com/stock/9587

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 / 33
FUTURE 0 / 14
PAST 17 / 21
HEALTH 97 / 97
DIVIDEND 0 / 52

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Aug 1, 2026).

Stock Price Fair Value vs Fair Value
McKesson Corporation M1CK34 R$999.49 R$1,236 +24%
Cencora, Inc COR $270.32 $168.24 -38%
Cardinal Health, Inc CAH $201.74 $92.07 -54%
Sigma Healthcare Limited SIGGF $2.35 $0.6300 -73%
Henry Schein, Inc HSIC $78.85 $62.37 -21%
Shanghai Pharmaceuticals Holding 601607 ¥15.96 ¥45.15 +183%
Sinopharm Group 1099 HK$16.74 HK$61.33 +266%
Galenica AG GALNF $115.00 $84.59 -26%
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥20.81 ¥30.70 +48%
Medipal Holdings MEPDF $18.35 $29.88 +63%

Compare Lana Medical Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Lana Medical Company (9587) overvalued or undervalued?
As of Aug 1, 2026, our model estimates a fair value of 1.00 SAR versus a price of 2.50 SAR, about −60% (overvalued).
What is the fair value of 9587?
Our model-based fair value for Lana Medical Company is 1.00 SAR (as of Aug 1, 2026), built from audited fundamentals. The current price is 2.50 SAR.
What is the quality score of 9587?
Lana Medical Company has a Quality Score of 26/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Lana Medical Company (9587)?
Lana Medical Company reported trailing-twelve-month revenue of about 92.3M SAR (latest available figure, as of Aug 1, 2026).
What is the net profit margin of 9587?
The net profit margin of Lana Medical Company is about 2.9%, meaning it keeps roughly 2.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Lana Medical Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.